Document is current
Any future updates will be listed below
-
Authors
Weisbart, Erin http://orcid.org/0000-0002-6437-2458
Kumar, Ankur http://orcid.org/0000-0002-7686-7335
Arevalo, John http://orcid.org/0000-0002-1138-5036
Carpenter, Anne E. http://orcid.org/0000-0003-1555-8261
Cimini, Beth A. http://orcid.org/0000-0001-9640-9318
Singh, Shantanu http://orcid.org/0000-0003-3150-3025
-
Funding
Funding for this research was provided by:
Calico Life Sciences LLC
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (GM135019, GM135019, GM122547)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
Merck & Co., Inc. | Merck Sharp and Dohme
- License Information
-
More Information
Article History
First Online: 2 September 2024
Competing interests
: S.S. and A.E.C. serve as scientific advisors for companies that use image-based profiling and Cell Painting (A.E.C: Recursion, SyzOnc, Quiver Bioscience, S.S.: Waypoint Bio, Dewpoint Therapeutics, Deepcell) and receive honoraria for occasional talks at pharmaceutical and biotechnology companies. The other authors declare no competing interests.
